PTC Therapeutics Inc (PTCT) Insider Trading
- $31,673,582.00
- $150,166,253.29
- April 19, 2024
- Stuart Walter Peltz
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 19, 2024 | CEO | 3,361 | $24.89 | Sell | $83,655.29 | |
April 17, 2024 | CEO | 787 | $25.14 | Sell | $19,785.18 | |
April 2, 2024 | EVP | 526 | $28.37 | Sell | $14,922.62 | |
Jan. 30, 2024 | CAO | 318 | $27.25 | Sell | $8,665.50 | |
Jan. 30, 2024 | VP | 794 | $27.25 | Sell | $21,636.50 | |
Jan. 30, 2024 | Insider | 618 | $27.25 | Sell | $16,840.50 | |
Jan. 22, 2024 | Director | 10,000 | $27.38 | Sell | $273,800.00 | |
Jan. 8, 2024 | VP | 1,457 | $28.64 | Sell | $41,728.48 | |
Jan. 8, 2024 | CEO | 2,237 | $28.64 | Sell | $64,067.68 | |
Jan. 8, 2024 | CAO | 1,188 | $28.64 | Sell | $34,024.32 | |
Jan. 8, 2024 | Director | 1,500 | $27.81 | Sell | $41,715.00 | |
Jan. 8, 2024 | Insider | 1,569 | $28.64 | Sell | $44,936.16 | |
Jan. 5, 2024 | CEO | 10,107 | $27.15 | Sell | $274,405.05 | |
Dec. 12, 2023 | CFO | 7,700 | $25.81 | Buy | $198,737.00 | |
Sept. 6, 2023 | Director | 11,666 | $39.86 | Sell | $465,006.76 | |
May 11, 2023 | Director | 23,000 | $55.08 | Sell | $1,266,840.00 | |
April 21, 2023 | Director | 4,328 | $55.05 | Sell | $238,256.40 | |
April 21, 2023 | CAO | 4,692 | $55.06 | Sell | $258,341.52 | |
April 18, 2023 | Insider | 732 | $52.04 | Sell | $38,093.28 | |
April 18, 2023 | CEO | 1,211 | $52.04 | Sell | $63,020.44 | |
April 17, 2023 | Director | 11,429 | $51.03 | Sell | $583,221.87 | |
April 17, 2023 | VP | 61,923 | $51.42 | Sell | $3,184,080.66 | |
March 31, 2023 | Director | 2,571 | $50.05 | Sell | $128,678.55 | |
March 29, 2023 | CAO | 4,688 | $47.79 | Sell | $224,039.52 | |
March 27, 2023 | CFO | 7,363 | $45.00 | Sell | $331,335.00 | |
March 27, 2023 | Director | 10,000 | $45.10 | Sell | $451,000.00 | |
March 27, 2023 | CAO | 26,658 | $45.09 | Sell | $1,202,009.22 | |
Jan. 31, 2023 | CEO | 2,320 | $45.63 | Sell | $105,861.60 | |
Jan. 31, 2023 | CFO | 575 | $45.63 | Sell | $26,237.25 | |
Jan. 31, 2023 | CAO | 325 | $45.63 | Sell | $14,829.75 | |
Jan. 31, 2023 | VP | 812 | $45.63 | Sell | $37,051.56 | |
Jan. 31, 2023 | Insider | 375 | $45.63 | Sell | $17,111.25 | |
Jan. 24, 2023 | CEO | 284 | $47.45 | Sell | $13,475.80 | |
Jan. 24, 2023 | Insider | 359 | $47.45 | Sell | $17,034.55 | |
Jan. 24, 2023 | CFO | 223 | $47.45 | Sell | $10,581.35 | |
Jan. 11, 2023 | VP | 495 | $44.36 | Sell | $21,958.20 | |
Jan. 11, 2023 | CFO | 418 | $44.36 | Sell | $18,542.48 | |
Jan. 11, 2023 | CAO | 417 | $44.36 | Sell | $18,498.12 | |
Jan. 11, 2023 | CEO | 1,189 | $44.36 | Sell | $52,744.04 | |
Jan. 11, 2023 | Insider | 383 | $44.36 | Sell | $16,989.88 | |
Jan. 11, 2023 | COO | 2,244 | $44.36 | Sell | $99,543.84 | |
Jan. 9, 2023 | CEO | 1,786 | $41.66 | Sell | $74,404.76 | |
Jan. 9, 2023 | Insider | 716 | $41.66 | Sell | $29,828.56 | |
Jan. 9, 2023 | CAO | 706 | $41.66 | Sell | $29,411.96 | |
Jan. 9, 2023 | COO | 731 | $41.66 | Sell | $30,453.46 | |
Jan. 9, 2023 | VP | 835 | $41.66 | Sell | $34,786.10 | |
Jan. 9, 2023 | CFO | 758 | $41.66 | Sell | $31,578.28 | |
Oct. 18, 2022 | VP | 299 | $55.06 | Sell | $16,462.94 | |
Sept. 20, 2022 | VP | 1,176 | $55.00 | Sell | $64,680.00 | |
Aug. 9, 2022 | Director | 2,296 | $51.62 | Sell | $118,519.52 |
Insiders are both buying and selling PTC Therapeutics Inc stock.
The insider traders at PTC Therapeutics Inc are: Stuart Walter Peltz, Christine Marie Utter, Mark Elliott Boulding, Emily Luisa Hill, Neil Gregory Almstead, Mark Rothera, Eric Pauwels, Allan Steven Jacobson, Matthew B Klein, Claudia De Oliveira Ri Hirawat, David P Southwell, Marcio Souza, Dawn Svoronos, Stephanie Okey, Shane William Charles Kovacs, Michael Schmertzler, Hbm Healthcare Investments (Ca, Richard Aldrich, Robert J Spiegel, Robert Spiegel, Emma Reeve, Alethia Young, Lee Scott Golden, Adam Koppel, David Southwell, Matthew B. Klein, Michael Kranda, Michael L Kranda, and Pierre Gravier
The most active insider trader at PTC Therapeutics Inc is Stuart Walter Peltz with 31 trades.
Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.
Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.
The most recent insider trade for PTC Therapeutics Inc was on April 19, 2024.
The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.
The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.